| Jodi Fichera, MD | |
|
5301 Mcauley Dr, Ypsilanti, MI 48197-1051 | |
| (734) 712-3325 | |
| (743) 712-5525 |
| Full Name | Jodi Fichera |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 5301 Mcauley Dr, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427062579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 068419 (Michigan) | Secondary |
| 208000000X | Pediatrics | 4301068419 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jodi Fichera, MD 24 Frank Lloyd Wright Dr Ste J2000, Ann Arbor, MI 48105-9484 Ph: (734) 747-6766 | Jodi Fichera, MD 5301 Mcauley Dr, Ypsilanti, MI 48197-1051 Ph: (734) 712-3325 |
News Archive
Taking a new approach to the treatment and prevention of Alzheimer's disease, a research team led by investigators at the Mayo Clinic campus in Florida has shown that druglike compounds can speed up destruction of the amyloid beta (A-beta) proteins that form plaque in the brains of patients with the disorder.
To see what cognitive therapy looked like, ProPublica and NPR spent several days with McKinney and fellow soldiers and veterans at Project Share, a charity to help brain-damaged soldiers. (This article is part of an ongoing investigation.) The program is based out of the Shepherd Center for Brain and Spinal Cord Injury in Atlanta, a nationally recognized hospital for head injuries (Miller and Zwerdling, 12/21).
Risk of congestive heart failure in women treated with trastuzumab (Herceptin) and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project (NSABP) trial B-31, presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
› Verified 9 days ago
Lindsey Nicole Farah-brunner, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5301 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-3325 Fax: 734-712-5525 | |
Dr. Samuel Abebe, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5593 Redbud Ct, Ypsilanti, MI 48197 Phone: 734-846-2547 | |
Dr. Sandra B Cadichon, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5301 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-3327 Fax: 734-712-5525 | |
Yolaine A Civil, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 200 Arnet St, Suite 200, Ypsilanti, MI 48198 Phone: 734-484-7288 | |
Elizabeth Marjorie Stone, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4936 West Clark Rd., Suite 101, Ypsilanti, MI 48197 Phone: 734-434-3000 Fax: 734-434-8040 | |
Eliza Gardiner Stensland, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5301 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-3325 Fax: 734-712-5525 | |
Dr. Bradley Judge, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5301 E Huron River Dr, Department Of Pediatrics, Ypsilanti, MI 48197 Phone: 734-712-3325 |